Case Report
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 6, 2022; 10(16): 5414-5419
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5414
Successful living donor liver transplantation with a graft-to-recipient weight ratio of 0.41 without portal flow modulation: A case report
Seong Hoon Kim
Seong Hoon Kim, Center for Liver Cancer, National Cancer Center, Goyang 10408, Gyeonggi-do, South Korea
Author contributions: Kim SH conceived and designed the analysis, collected the data, performed the analysis, and wrote the paper.
Informed consent statement: Written informed consent was obtained from the patient for publication of this case report.
Conflict-of-interest statement: The author of this manuscript has no conflicts of interest to disclose.
CARE Checklist (2016) statement: I present the case in accordance with the CARE reporting checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Seong Hoon Kim, MD, PhD, Chief Doctor, Professor, Senior Scientist, Surgeon, Center for Liver Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Gyeonggi-do, South Korea. kshlj@hanmail.net
Received: September 17, 2021
Peer-review started: September 17, 2021
First decision: November 7, 2021
Revised: November 12, 2021
Accepted: April 22, 2022
Article in press: April 22, 2022
Published online: June 6, 2022
Core Tip

Core Tip: Satisfactory outcomes was achieved in living donor liver transplantation with a graft-to-recipient weight ratio as low as 0.41%, the smallest to be reported in the literature, even without using portal flow modulation in a highly selected patient.